Both in Pharmaceuticals
Immunic vs OnKure Therapeutics
Over the past year IMUX returned +14.9% and OKUR returned −16.5%; their daily moves had a correlation of -0.01.
IMUX +14.9% OKUR −16.5%Growth of $1, one year, split-adjusted
| Metric | IMUX | OKUR |
|---|---|---|
| Price | $7.94 | $2.59 |
| Market cap | $108.3M | $104.9M |
| Today | +4.47% | +3.60% |
| 1 month | +1.5% | +5.3% |
| 6 months | −27.9% | −36.4% |
| Year to date | +48.8% | −10.7% |
| 1 year | +6.1% | −20.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $155.1M | $176.4M |
| Dividend yield | — | — |
| Volatility (60d) | 73.5% | 56.2% |
| Short % of float | 17.5% | 5.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).